UCB SA (UCB-BT)

QUOTE AND NEWS
The Hindu Business Line  Apr 1  Comment 
Pharma major Dr Reddy’s Laboratories will acquire certain products of Brussels-based biopharmaceutical company UCB in India, Nepal, Sri Lanka and Maldives for ₹800 crore. The ac...
Mondo Visione  Mar 26  Comment 
A jury convicted Ebrahim Shabudin yesterday of seven felony counts of conspiracy, securities fraud and other corporate fraud offenses stemming from the failure of United Commercial Bank (UCB), announced U.S. Attorney Melinda Haag of the Northern...
The Times of India  Mar 11  Comment 
Drugmaker Dr Reddy's Laboratories Ltd (REDY.NS) is in talks to acquire the Indian operations of Belgian pharmaceutical company UCB SA (UCB.BR) for about $135 million, said a person with direct knowledge of the matter.
Reuters  Mar 10  Comment 
Drugmaker Dr Reddy's Laboratories Ltd is in talks to acquire the Indian operations of Belgian pharmaceutical company UCB SA for about $135 million, said a person with direct knowledge of the matter.
Benzinga  Feb 27  Comment 
Belgian company UCB SA (OTC: UCBJY) reported a 30% gain in its net profit for 2014. UCB's net profit for the year climbed to 209 million euros ($234.39 million), while revenue gained 7% to EUR3.34 billion. Core earnings per share surged to €...
GenEng News  Jan 16  Comment 
San Diego-based Neuropore Therapies and Belgium firm UCB are collaborating to develop and market therapeutic products aimed at slowing the progression of Parkinson’s disease and related neurodegenerative disorders. UCB will pay the...
MedPage Today  Dec 18  Comment 
(MedPage Today) -- Lower inflammatory joint burden visible on MRI after 4 months of treatment.
TheStreet.com  Dec 17  Comment 
BRUSSELS ( The Deal) -- Belgium's UCB is putting Kremers Urban Pharmaceuticals back on the auction block after the collapse of the agreed $1.53 billion sale of the Princeton, N.J.-based generics business to Advent International and Avista Capital...
FiercePharma  Dec 17  Comment 
Weeks after Belgium's UCB announced that it would sell its U.S. generic drug business for $1.53 billion, the company is calling off the sale in light of regulatory pushback over one of the unit's products.





You may also be interested in articles related to UCB SA (UCB-BT):
 
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki